The FDA announced today that it authorized the Q-Collar made by Q30 Sports Science for protecting the brain during sports activities. Q30 Sports Science’s Q-Collar is a C-shaped collar worn around the neck designed to apply compressive force to the neck and increase blood volume to help reduce movement of the brain within the cranial […]
Neurological
Welcome to MassDevice's Neurological Hub, your resource for the latest news in the neurological device space. Stay informed about the innovations and business news shaping the neurological industry.
🧠 Narrow your focus with these categories:
Neuromodulation/Neurostimulation | Bioelectronic Medicine | Pain Management | Brain-Computer Interfaces
Here are the top neurological device features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ 7 brain-computer interface companies you need to know
+ Brain breakthroughs: Aprinoia Therapeutics’ harnesses AI and strategic partnerships to propel neurodegenerative disease research
+ Natalizumab and PML: The complex dance of benefit and risk for MS
Latest Neurological News
LivaNova slides despite Street-beating Q4
LivaNova (NSDQ:LIVN) shares took a dip this morning despite fourth-quarter results that topped the consensus forecast. The London-based company posted losses of $279.8 million, or -$5.75 per share, on sales of $269.6 million for the three months ended Dec. 31, 2020, for a 95.4% bottom-line slide deeper into the red on a sales decline of -6.3%. […]
FDA approves expanded labeling for Medtronic InterStim SureScan MRI leads
Medtronic (NYSE:MDT) announced today that it received FDA approval for expanded MRI labeling of its InterStim SNM systems. Fridley, Minn.-based Medtronic’s InterStim II and InterStim Micro sacral neuromodulation (SNM) systems that use SureScan MRI leads were approved under updated MRI guidelines allowing for a wider range of MRI scan parameters and shorter wait times between scans, […]
Cerus Endovascular neurovascular system wins FDA breakthrough device designation
Cerus Endovascular today said it has received FDA breakthrough device designation for its Contour Neurovascular System. The Contour Neurovascular System is designed to treat intracranial aneurysms. It is made of fine mesh braid to target the neck of the aneurysm away from the vulnerable dome. It can be self-anchored for stability, is re-sheathable for precise […]
NeuroMetrix slides on Q4 losses
NeuroMetrix (NSDQ:NURO) shares dipped today on fourth-quarter results that showcased losses despite an improved bottom line. The Woburn, Mass.-based company posted losses of -$325,767 on sales of $1.8 million for the three months ended Dec. 31, 2020, for a 69.2% bottom-line gain on sales growth of 6%. NeuroMetrix experienced headwinds from the COVID-19 pandemic and felt […]
FDA clears Theranica device for adolescent migraines
Theranica announced today that the FDA has granted expanded clearance for the use of its Nerivio acute migraine treatment device by people 12 years and older. The use of the device in the treatment of adolescents is supported by a study recently published in Headache. According to the study, 28 of 39 (71%) of the adolescent participants using […]
FDA approves Boston Scientific Vercise Genus deep brain stimulation system
Boston Scientific (NYSE:BSX) announced today that it received FDA approval for its fourth-generation Vercise Genus DBS system. Marlborough, Mass.-based Boston Scientific’s Vercise Genus deep brain stimulation (DBS) system portfolio is approved for conditional use in a magnetic resonance imaging (MRI) environment. It features a family of Bluetooth-enabled, rechargeable and non-rechargeable implantable pulse generators capable of powering […]
Medtronic launches deep brain stim trial for Parkinson’s disease
Medtronic (NYSE:MDT) announced that it made the first enrollment in the Adapt-PD trial for adaptive deep brain stimulation. Fridley, Minn.-based Medtronic’s Adapt-PD trial is evaluating the safety and efficacy of aDBS in patients with Parkinson’s Disease, according to a news release. If approved, aDBS could be enabled as an investigational feature of the Percept PC device […]
Boston Scientific’s preliminary Q4 results show 6.8% revenue decline
Boston Scientific (NYSE:BSX) announced today that its fourth-quarter net sales represent an approximate decline of 6.8% year-over-year. Marlborough, Mass.-based Boston Scientific’s estimation of $2.71 billion in fourth-quarter revenue brings its full-year 2020 sales total to approximately $9.91 billion, marking a 7.7% total decline from 2019. Wall Street analysts on average had predicted $2.86 billion in revenue […]
FDA approves low-profile aneurysm embolization system
Terumo (TYO:4543) subsidiary MicroVention announced today that it received FDA approval of a PMA supplement for its WEB 17 system. Aliso Viejo, Calif.-based MicroVention’s WEB 17 system is a new addition to its WEB aneurysm embolization system for treating intracranial wide-neck bifurcation aneurysms, according to a news release. WEB 17 features a lower profile delivery system compatible […]
ClearMind neuroendoscope gains FDA clearance
ClearMind Biomedical announced today that it received FDA clearance for its Axonpen novel neuroendoscope system. Los Angeles-based ClearMind Biomedical’s Axonpen system is designed for the illumination and visualization of intracranial tissue and fluids, as well as the controlled aspiration of tissue and/or fluid during surgery, according to a news release. The system requires a 6.5 […]